Rockwell Medical Inc (RMTI) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.035x

Based on the latest financial reports, Rockwell Medical Inc (RMTI) has a cash flow conversion efficiency ratio of -0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.31 Million) by net assets ($37.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Rockwell Medical Inc - Cash Flow Conversion Efficiency Trend (1997–2024)

This chart illustrates how Rockwell Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Rockwell Medical Inc (RMTI) financial obligations for a breakdown of total debt and financial obligations.

Rockwell Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rockwell Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
DNA Biomed Solns
TA:DNA
-0.003x
Aallon Group Oyj
HE:AALLON
0.051x
Alticast Corporation
KQ:085810
0.104x
Man Group PLC
LSE:EMG
-0.090x
Eco Wave Power Global AB ADR
NASDAQ:WAVE
0.076x
Feng Ching Metal
TWO:2061
-0.030x
Lottery.com, Inc. Common Stock
NASDAQ:LTRY
-0.067x
Zaklady Magnezytowe Ropczyce S.A.
WAR:RPC
-0.006x

Annual Cash Flow Conversion Efficiency for Rockwell Medical Inc (1997–2024)

The table below shows the annual cash flow conversion efficiency of Rockwell Medical Inc from 1997 to 2024. For the full company profile with market capitalisation and key ratios, see Rockwell Medical Inc (RMTI) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $32.59 Million $4.20 Million 0.129x +129.17%
2023-12-31 $21.29 Million $-9.41 Million -0.442x +63.17%
2022-12-31 $14.11 Million $-16.93 Million -1.200x +90.93%
2021-12-31 $2.54 Million $-33.53 Million -13.228x -1424.96%
2020-12-31 $34.17 Million $-29.64 Million -0.867x +35.33%
2019-12-31 $20.32 Million $-27.25 Million -1.341x -79.17%
2018-12-31 $27.28 Million $-20.42 Million -0.749x -16.70%
2017-12-31 $32.91 Million $-21.11 Million -0.642x -172.81%
2016-12-31 $52.96 Million $-12.45 Million -0.235x +9.77%
2015-12-31 $62.32 Million $-16.24 Million -0.261x -520.51%
2014-12-31 $68.70 Million $4.26 Million 0.062x +100.07%
2013-12-31 $595.54K $-50.66 Million -85.074x -2856.37%
2012-12-31 $-9.96 Million $-30.75 Million 3.086x +622.23%
2011-12-31 $18.24 Million $-10.78 Million -0.591x -959.08%
2010-12-31 $30.54 Million $2.10 Million 0.069x +241.39%
2009-12-31 $29.32 Million $-1.43 Million -0.049x +86.53%
2008-12-31 $11.82 Million $-4.27 Million -0.361x -90.83%
2007-12-31 $17.96 Million $-3.40 Million -0.189x +53.49%
2006-12-31 $8.37 Million $-3.41 Million -0.407x -216.96%
2005-12-31 $3.84 Million $-493.52K -0.128x -142.79%
2004-12-31 $3.42 Million $1.03 Million 0.300x +322.10%
2003-12-31 $3.17 Million $225.42K 0.071x +119.41%
2002-12-31 $3.05 Million $-1.12 Million -0.366x -3.36%
2001-12-31 $2.60 Million $-920.02K -0.354x -104.25%
2000-12-31 $2.86 Million $-496.35K -0.173x +30.61%
1999-12-31 $3.60 Million $-900.00K -0.250x +50.00%
1998-12-31 $4.60 Million $-2.30 Million -0.500x +29.17%
1997-12-31 $1.70 Million $-1.20 Million -0.706x --

About Rockwell Medical Inc

NASDAQ:RMTI USA Drug Manufacturers - Specialty & Generic
Market Cap
$35.00 Million
Market Cap Rank
#23179 Global
#4820 in USA
Share Price
$0.89
Change (1 day)
+1.29%
52-Week Range
$0.79 - $1.83
All Time High
$141.02
About

Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterily… Read more